NCT01560416 2026-03-03Fulvestrant With or Without Ganetespib in HR+ Breast CancerDana-Farber Cancer InstitutePhase 2 Completed50 enrolled 14 charts
NCT01579994 2020-12-30Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung CancersMemorial Sloan Kettering Cancer CenterPhase 1 Completed13 enrolled
NCT00687934 2014-09-18Study of STA-9090, Administered Once-Weekly in Patients With Solid TumorsSynta Pharmaceuticals Corp.Phase 1 Completed53 enrolled